BB September 18th Options Begin Trading

Stock Options Channel highlights two option strategies on BlackBerry (BB, $3.92): selling a $3.50 put bid $0.36 would set an effective share cost basis of $3.14 (11% OTM) with a quoted 70% probability of expiring worthless and a 10.29% return on cash (15.26% annualized). Alternatively, selling a $4.50 covered call at a $0.45 bid (≈15% OTM) against shares bought at $3.92 yields a potential 26.28% total return if called on Sept. 18, with a 49% chance of expiring worthless and an 11.48% YieldBoost (17.04% annualized); implied vols are ~80% (put) and 64% (call) versus a 12-month realized volatility of 53%.

Analysis

Market structure: The option chain shows asymmetric demand — puts IV 80% vs calls 64% and realized 53% — indicating elevated downside hedging and richer put skew. Direct beneficiaries are option sellers (yield sellers, market makers, brokers like NDAQ via fees) while passive long holders face higher hedging costs and assignment risk; the 70% expire-worthless odds priced by the market imply modest tail protection demand but expensive hedges.

Risk assessment: Tail risks include an operational/earnings shock or licensing loss that could push BB < $2.00 (low-probability, high-impact) and spike IV >150%, causing large mark-to-market losses for short premium strategies. Immediate (days) risk is gamma around expiration (Sep 18); short-term (weeks/months) risk is IV mean-reversion toward ~53%; long-term (quarters) depends on fundamentals (cash runway, revenue cadence) and could make options cheaper or pricier.

Trade implications: For patient buyers, cash-secured put at $3.50 (net basis $3.14) offers ~10% cash yield to Sep 18 with 70% odds of expiry — attractive size for a 1–3% tactical allocation if willing to own the equity. If already long, selling the $4.50 call caps upside for a 26% pre-commission return to Sep 18; if expecting a negative catalyst, prefer defined-risk put spreads to buying naked puts given elevated IV.

Contrarian angles: The market may be overpricing downside as liquidity/hedging demand—not fundamentals—drives IV skew; selling premium can profit from IV mean reversion but is vulnerable to catalyst risk. Historical parallels (small-cap tech with episodic licensing/news-driven spikes) show sharp IV collapses post-catalyst; unintended consequence: aggressive put-selling can force concentrated long exposure if assigned during an adverse liquidity event.

Key Decisions for Investors

• Sell cash-secured BB Sep 18 $3.50 puts size = 1–3% portfolio notional (max 5% aggregate equity exposure), collect $0.36; target hold-to-expiration if IV<=80% and close if BB < $2.80 or IV spikes >120%.
• If assigned or already long BB, sell-to-open Sep 18 $4.50 covered calls size = underlying position to cap Sep return at ~26.3%; roll monthly only if premium >$0.30 and buy back if BB > $5.00 intraday.
• Construct a defined-risk bearish trade: buy Sep 18 $3.50 puts and sell Sep 18 $2.50 puts (1x1 vertical) to limit cost — allocate <=1% portfolio, close if BB trades below $2.20 or IV jumps >40 pts.
• Exploit IV skew: when front-month IV > realized+20 pts (e.g., >73%), sell near-term calendar spreads (sell front, buy 2–3 month) sized to 0.5–1% portfolio to capture theta if no adverse catalyst emerges; avoid long straddles while IV remains >70%.